OBALON THERAPEUTICS INC 4
4 · OBALON THERAPEUTICS INC · Filed May 2, 2017
Insider Transaction Report
Form 4
Rasdal Andrew P
DirectorPresident & CEO
Transactions
- Award
Common Stock
2017-04-30$9.03/sh+2,768$24,995→ 453,263 total
Holdings
- 450,495(indirect: By Trust)
Common Stock
Footnotes (2)
- [F1]These shares were acquired under the Obalon Therapeutics, Inc. 2016 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).
- [F2]The Reporting Person is the sole Trustee of shares held by a family trust for which the Reporting Person is the sole beneficiary.